Real-Time Trials Need Real-Time Data You Can Trust

The FDA's move toward real-time clinical trials could mark one of the most significant changes to drug development in decades. By enabling regulators to review safety signals and study data as trials progress, the industry has an opportunity to shorten timelines, accelerate decisions, and bring promising therapies to patients faster.

But faster data transmission raises an important question: can sponsors trust the data flowing through increasingly connected trial ecosystems? Clinical studies rely on dozens of teams, systems, and processes that all originate from a single protocol, yet interpretation and execution often occur in parallel. As real-time reporting becomes a reality, inconsistencies that have long existed behind the scenes may become impossible to ignore.

Discover why protocol digitization is emerging as a critical foundation for scalable real-time trials and what it could mean for the future of clinical research.